

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 9.54385789 |
| 2 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.39226126 |
| 3 | regulation of apoptotic cell clearance (GO:2000425) | 9.28362826 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.77204914 |
| 5 | DNA deamination (GO:0045006) | 8.30149048 |
| 6 | regulation of integrin activation (GO:0033623) | 7.55146423 |
| 7 | regulation of complement activation (GO:0030449) | 6.55224111 |
| 8 | regulation of protein activation cascade (GO:2000257) | 6.47348698 |
| 9 | complement activation (GO:0006956) | 6.35382135 |
| 10 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 6.30040030 |
| 11 | opsonization (GO:0008228) | 6.26680646 |
| 12 | mannose metabolic process (GO:0006013) | 6.05517616 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 6.00621997 |
| 14 | eosinophil chemotaxis (GO:0048245) | 5.95702965 |
| 15 | eosinophil migration (GO:0072677) | 5.90522925 |
| 16 | apoptotic cell clearance (GO:0043277) | 5.74910247 |
| 17 | lipoxygenase pathway (GO:0019372) | 5.61763563 |
| 18 | citrulline biosynthetic process (GO:0019240) | 5.50264575 |
| 19 | regulation of humoral immune response (GO:0002920) | 5.38674311 |
| 20 | negative regulation by host of viral transcription (GO:0043922) | 5.35277621 |
| 21 | complement activation, classical pathway (GO:0006958) | 5.32272207 |
| 22 | germinal center formation (GO:0002467) | 5.24976822 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18243674 |
| 24 | protein carboxylation (GO:0018214) | 5.18243674 |
| 25 | positive regulation of calcium-mediated signaling (GO:0050850) | 5.17846881 |
| 26 | protein activation cascade (GO:0072376) | 5.11272512 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.06292342 |
| 28 | response to interleukin-15 (GO:0070672) | 5.01083837 |
| 29 | cytolysis (GO:0019835) | 4.93700092 |
| 30 | endothelial cell chemotaxis (GO:0035767) | 4.91641070 |
| 31 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.83320541 |
| 32 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.82165376 |
| 33 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.81624781 |
| 34 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.77854133 |
| 35 | T cell migration (GO:0072678) | 4.69119129 |
| 36 | regulation of endothelial cell chemotaxis (GO:2001026) | 4.65401759 |
| 37 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.58259693 |
| 38 | positive thymic T cell selection (GO:0045059) | 4.51974122 |
| 39 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.26971654 |
| 40 | positive regulation of B cell differentiation (GO:0045579) | 4.23639373 |
| 41 | positive T cell selection (GO:0043368) | 4.23528986 |
| 42 | phospholipid efflux (GO:0033700) | 4.22849849 |
| 43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.22398188 |
| 44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.20624561 |
| 45 | macrophage chemotaxis (GO:0048246) | 4.19075908 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 4.18939046 |
| 47 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.17041038 |
| 48 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.17041038 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.13102835 |
| 50 | L-phenylalanine catabolic process (GO:0006559) | 4.13102835 |
| 51 | regulation of macrophage chemotaxis (GO:0010758) | 4.10983854 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 4.09987569 |
| 53 | positive regulation of lymphocyte migration (GO:2000403) | 4.01390978 |
| 54 | negative T cell selection (GO:0043383) | 4.00592507 |
| 55 | regulation of T cell chemotaxis (GO:0010819) | 3.98857307 |
| 56 | positive regulation of T cell chemotaxis (GO:0010820) | 3.98857307 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.98421434 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.98240575 |
| 59 | L-phenylalanine metabolic process (GO:0006558) | 3.98240575 |
| 60 | negative regulation of viral genome replication (GO:0045071) | 3.96404310 |
| 61 | killing of cells of other organism (GO:0031640) | 3.95274264 |
| 62 | disruption of cells of other organism (GO:0044364) | 3.95274264 |
| 63 | urea cycle (GO:0000050) | 3.93668362 |
| 64 | urea metabolic process (GO:0019627) | 3.93668362 |
| 65 | granulocyte activation (GO:0036230) | 3.93489968 |
| 66 | cellular extravasation (GO:0045123) | 3.92856033 |
| 67 | negative regulation of fibrinolysis (GO:0051918) | 3.90751762 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.90724746 |
| 69 | high-density lipoprotein particle remodeling (GO:0034375) | 3.89230226 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88958095 |
| 71 | regulation of chronic inflammatory response (GO:0002676) | 3.85204101 |
| 72 | regulation of activation of Janus kinase activity (GO:0010533) | 3.84522547 |
| 73 | thymic T cell selection (GO:0045061) | 3.83462477 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.81919957 |
| 75 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.81489590 |
| 76 | regulation of calcium-mediated signaling (GO:0050848) | 3.78679152 |
| 77 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.77049988 |
| 78 | alpha-linolenic acid metabolic process (GO:0036109) | 3.76542497 |
| 79 | citrulline metabolic process (GO:0000052) | 3.74281709 |
| 80 | aromatic amino acid family catabolic process (GO:0009074) | 3.73467336 |
| 81 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.72971211 |
| 82 | positive regulation of hemostasis (GO:1900048) | 3.69950166 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 3.69950166 |
| 84 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.69027218 |
| 85 | actin nucleation (GO:0045010) | 3.68344290 |
| 86 | reverse cholesterol transport (GO:0043691) | 3.67631822 |
| 87 | negative regulation of viral transcription (GO:0032897) | 3.67462621 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.64503810 |
| 89 | negative regulation of granulocyte differentiation (GO:0030853) | 3.64388733 |
| 90 | positive regulation of coagulation (GO:0050820) | 3.62864970 |
| 91 | nitrogen cycle metabolic process (GO:0071941) | 3.60796687 |
| 92 | regulation of B cell differentiation (GO:0045577) | 3.60231011 |
| 93 | negative regulation of cell killing (GO:0031342) | 3.60144971 |
| 94 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.60144971 |
| 95 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.56422935 |
| 96 | regulation of fibrinolysis (GO:0051917) | 3.56301137 |
| 97 | negative regulation of T cell apoptotic process (GO:0070233) | 3.50485321 |
| 98 | regulation of gamma-delta T cell activation (GO:0046643) | 3.49249143 |
| 99 | positive regulation of cell killing (GO:0031343) | 3.47762106 |
| 100 | positive regulation of Rap GTPase activity (GO:0032854) | 3.46977304 |
| 101 | bile acid biosynthetic process (GO:0006699) | 3.44467433 |
| 102 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.42641137 |
| 103 | defense response to fungus (GO:0050832) | 3.42282433 |
| 104 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.42094506 |
| 105 | T cell selection (GO:0045058) | 3.41229103 |
| 106 | innate immune response in mucosa (GO:0002227) | 3.41073376 |
| 107 | lymphocyte chemotaxis (GO:0048247) | 3.40512556 |
| 108 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.39227596 |
| 109 | cholesterol efflux (GO:0033344) | 3.39068609 |
| 110 | positive regulation of defense response to virus by host (GO:0002230) | 3.38949299 |
| 111 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.38512102 |
| 112 | negative thymic T cell selection (GO:0045060) | 3.36622956 |
| 113 | regulation of cholesterol storage (GO:0010885) | 3.35627664 |
| 114 | cellular defense response (GO:0006968) | 3.34066899 |
| 115 | plasma lipoprotein particle assembly (GO:0034377) | 3.33177093 |
| 116 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.32303220 |
| 117 | tryptophan catabolic process (GO:0006569) | 3.31949027 |
| 118 | indole-containing compound catabolic process (GO:0042436) | 3.31949027 |
| 119 | indolalkylamine catabolic process (GO:0046218) | 3.31949027 |
| 120 | protein-lipid complex remodeling (GO:0034368) | 3.31628791 |
| 121 | macromolecular complex remodeling (GO:0034367) | 3.31628791 |
| 122 | plasma lipoprotein particle remodeling (GO:0034369) | 3.31628791 |
| 123 | low-density lipoprotein particle remodeling (GO:0034374) | 3.31626870 |
| 124 | positive regulation of tolerance induction (GO:0002645) | 3.30204175 |
| 125 | negative regulation of interleukin-12 production (GO:0032695) | 3.30142945 |
| 126 | glyoxylate metabolic process (GO:0046487) | 3.30087107 |
| 127 | regulation of natural killer cell differentiation (GO:0032823) | 3.29924903 |
| 128 | kynurenine metabolic process (GO:0070189) | 3.29159354 |
| 129 | protein-lipid complex assembly (GO:0065005) | 3.27851835 |
| 130 | regulation of T cell tolerance induction (GO:0002664) | 3.26754477 |
| 131 | fibrinolysis (GO:0042730) | 3.26576634 |
| 132 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.23456142 |
| 133 | lymphocyte costimulation (GO:0031294) | 3.22768604 |
| 134 | regulation of phagocytosis (GO:0050764) | 3.22272799 |
| 135 | negative regulation of cholesterol transport (GO:0032375) | 3.19208484 |
| 136 | negative regulation of sterol transport (GO:0032372) | 3.19208484 |
| 137 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.18815237 |
| 138 | T cell mediated immunity (GO:0002456) | 3.18755746 |
| 139 | T cell costimulation (GO:0031295) | 3.17115203 |
| 140 | regulation of regulatory T cell differentiation (GO:0045589) | 3.16631682 |
| 141 | chronic inflammatory response (GO:0002544) | 3.16410286 |
| 142 | sulfur amino acid catabolic process (GO:0000098) | 3.15425226 |
| 143 | tryptophan metabolic process (GO:0006568) | 3.15395466 |
| 144 | positive regulation of T cell apoptotic process (GO:0070234) | 3.14976972 |
| 145 | regulation of triglyceride catabolic process (GO:0010896) | 3.14772560 |
| 146 | negative regulation of viral process (GO:0048525) | 3.14512328 |
| 147 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.13897946 |
| 148 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13108093 |
| 149 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13108093 |
| 150 | leukotriene metabolic process (GO:0006691) | 3.11675443 |
| 151 | regulation of cell killing (GO:0031341) | 3.10985898 |
| 152 | antibacterial humoral response (GO:0019731) | 3.09155594 |
| 153 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.08984429 |
| 154 | regulation of lymphocyte migration (GO:2000401) | 3.08929154 |
| 155 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06851156 |
| 156 | acute-phase response (GO:0006953) | 3.06764006 |
| 157 | regulation of mononuclear cell migration (GO:0071675) | 3.05748687 |
| 158 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04192696 |
| 159 | neutrophil activation (GO:0042119) | 3.04043551 |
| 160 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.03940369 |
| 161 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.03702402 |
| 162 | immunoglobulin mediated immune response (GO:0016064) | 3.03304086 |
| 163 | monocyte chemotaxis (GO:0002548) | 3.03043241 |
| 164 | regulation of T cell migration (GO:2000404) | 3.02980635 |
| 165 | positive regulation of cholesterol efflux (GO:0010875) | 3.00968428 |
| 166 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.99271639 |
| 167 | DNA demethylation (GO:0080111) | 2.97476048 |
| 168 | positive regulation of cholesterol transport (GO:0032376) | 2.95425064 |
| 169 | positive regulation of sterol transport (GO:0032373) | 2.95425064 |
| 170 | low-density lipoprotein particle clearance (GO:0034383) | 2.94362659 |
| 171 | bile acid metabolic process (GO:0008206) | 2.92789011 |
| 172 | cysteine metabolic process (GO:0006534) | 2.92688470 |
| 173 | detection of external biotic stimulus (GO:0098581) | 2.89345251 |
| 174 | regulation of interleukin-8 secretion (GO:2000482) | 2.87059536 |
| 175 | regulation of Rap GTPase activity (GO:0032317) | 2.85118817 |
| 176 | regulation of viral genome replication (GO:0045069) | 2.83858532 |
| 177 | antimicrobial humoral response (GO:0019730) | 2.83392773 |
| 178 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.82718935 |
| 179 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.81578673 |
| 180 | positive regulation of humoral immune response (GO:0002922) | 2.80631137 |
| 181 | acylglycerol homeostasis (GO:0055090) | 2.80278810 |
| 182 | triglyceride homeostasis (GO:0070328) | 2.80278810 |
| 183 | mucosal immune response (GO:0002385) | 2.79912832 |
| 184 | lymphocyte migration (GO:0072676) | 2.79583374 |
| 185 | protein-lipid complex subunit organization (GO:0071825) | 2.79046573 |
| 186 | plasma lipoprotein particle organization (GO:0071827) | 2.78618766 |
| 187 | regulation of tolerance induction (GO:0002643) | 2.77359270 |
| 188 | positive regulation of interleukin-17 production (GO:0032740) | 2.76769244 |
| 189 | modulation by host of symbiont transcription (GO:0052472) | 2.75474227 |
| 190 | modulation by host of viral transcription (GO:0043921) | 2.75474227 |
| 191 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 2.74420788 |
| 192 | chemokine-mediated signaling pathway (GO:0070098) | 2.72684773 |
| 193 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.71922152 |
| 194 | leukocyte aggregation (GO:0070486) | 2.71286936 |
| 195 | positive regulation of interleukin-4 production (GO:0032753) | 2.71127713 |
| 196 | cytidine metabolic process (GO:0046087) | 10.7033076 |
| 197 | cytidine catabolic process (GO:0006216) | 10.7033076 |
| 198 | cytidine deamination (GO:0009972) | 10.7033076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.34309522 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.32842828 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.04740754 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.52701610 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.29671244 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.15075146 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.14074036 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.07868736 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.98127681 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.31931235 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.99015683 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.99012447 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94142629 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.92031860 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.90868139 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72746898 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.67468771 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.65523189 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.61405178 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.61069083 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.59230341 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.58951502 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.58040572 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22655322 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.20654347 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19672120 |
| 27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19618199 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 2.14588299 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.13884595 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90301730 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84831816 |
| 32 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.79382128 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68940608 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66465322 |
| 35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.66448812 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.66358916 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.56920833 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.55476951 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54378346 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54320324 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48374258 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47827541 |
| 43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.46865153 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46010957 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42714806 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38309108 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.36499532 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36489953 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32816356 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32576867 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32247815 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30207796 |
| 53 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.27648091 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27145059 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25541184 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25100282 |
| 57 | GATA2_19941826_ChIP-Seq_K562_Human | 1.20939876 |
| 58 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.20538946 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20379948 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.18990695 |
| 61 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.18120775 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16769388 |
| 63 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16438907 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15890966 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14296469 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12956552 |
| 67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12170495 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11902970 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11721758 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11040138 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11017299 |
| 72 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10565282 |
| 73 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09652932 |
| 74 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09212555 |
| 75 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07362193 |
| 76 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07305506 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06830676 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05169602 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03604453 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03405399 |
| 81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02974290 |
| 82 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02898169 |
| 83 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01775260 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01704718 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99664199 |
| 86 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99309042 |
| 87 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98531906 |
| 88 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.98015644 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97228579 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96617519 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95843942 |
| 92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95182035 |
| 93 | MAF_26560356_Chip-Seq_TH1_Human | 0.95058576 |
| 94 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.93892926 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93535396 |
| 96 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93245428 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93213173 |
| 98 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.92742383 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91622297 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91534104 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90622935 |
| 102 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90023608 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90009435 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89898226 |
| 105 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89411925 |
| 106 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88835556 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88543810 |
| 108 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.87466619 |
| 109 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87376115 |
| 110 | P300_27268052_Chip-Seq_Bcells_Human | 0.87166218 |
| 111 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86991825 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86319048 |
| 113 | MYC_22102868_ChIP-Seq_BL_Human | 0.85749365 |
| 114 | GATA3_26560356_Chip-Seq_TH1_Human | 0.85609246 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.85592712 |
| 116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84985298 |
| 117 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84270091 |
| 118 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.84231148 |
| 119 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.83378415 |
| 120 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83229702 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83092866 |
| 122 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.81686835 |
| 123 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.81185684 |
| 124 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.80606783 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80296084 |
| 126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.79262808 |
| 127 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79177653 |
| 128 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78661726 |
| 129 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.78657200 |
| 130 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78231550 |
| 131 | MYB_26560356_Chip-Seq_TH2_Human | 0.78028935 |
| 132 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77814160 |
| 133 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77058517 |
| 134 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.74618024 |
| 135 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.74022348 |
| 136 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.74022348 |
| 137 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73848144 |
| 138 | UTX_26944678_Chip-Seq_JUKART_Human | 0.72345454 |
| 139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71896134 |
| 140 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.70574924 |
| 141 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70305203 |
| 142 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69990699 |
| 143 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.69853702 |
| 144 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.69849332 |
| 145 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.69730129 |
| 146 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69501357 |
| 147 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69153539 |
| 148 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.69059039 |
| 149 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.68492658 |
| 150 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.68345064 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.68228893 |
| 152 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.68124878 |
| 153 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.67911626 |
| 154 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.66366794 |
| 155 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66176712 |
| 156 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.66050539 |
| 157 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.65557727 |
| 158 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.65557727 |
| 159 | SA1_27219007_Chip-Seq_Bcells_Human | 0.65189791 |
| 160 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.65086550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.01564552 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.66384489 |
| 3 | MP0005360_urolithiasis | 4.64080880 |
| 4 | MP0009840_abnormal_foam_cell | 4.55189818 |
| 5 | MP0005365_abnormal_bile_salt | 3.54477539 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.38216186 |
| 7 | MP0003436_decreased_susceptibility_to | 3.08751764 |
| 8 | MP0003045_fibrosis | 2.92167990 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.87493421 |
| 10 | MP0004147_increased_porphyrin_level | 2.87189665 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.84755618 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.84327995 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.75740426 |
| 14 | MP0003724_increased_susceptibility_to | 2.71954372 |
| 15 | MP0001790_abnormal_immune_system | 2.59136742 |
| 16 | MP0005387_immune_system_phenotype | 2.59136742 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.53337948 |
| 18 | MP0000685_abnormal_immune_system | 2.39743528 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.29993351 |
| 20 | MP0003252_abnormal_bile_duct | 2.19056748 |
| 21 | MP0005025_abnormal_response_to | 2.15146943 |
| 22 | MP0003303_peritoneal_inflammation | 2.14332863 |
| 23 | MP0003075_altered_response_to | 2.08529998 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.06905434 |
| 25 | * MP0002419_abnormal_innate_immunity | 2.02116630 |
| 26 | MP0001835_abnormal_antigen_presentation | 2.00913728 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.92477563 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.88190617 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.86376934 |
| 30 | MP0003448_altered_tumor_morphology | 1.82469953 |
| 31 | MP0000604_amyloidosis | 1.81655334 |
| 32 | MP0000609_abnormal_liver_physiology | 1.81216303 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.79834724 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.79365353 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.78545205 |
| 36 | MP0004947_skin_inflammation | 1.76524460 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.76306552 |
| 38 | MP0005451_abnormal_body_composition | 1.74179712 |
| 39 | MP0005332_abnormal_amino_acid | 1.74129971 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.69541595 |
| 41 | MP0004510_myositis | 1.68840251 |
| 42 | MP0005083_abnormal_biliary_tract | 1.67317864 |
| 43 | MP0001873_stomach_inflammation | 1.65630764 |
| 44 | MP0005670_abnormal_white_adipose | 1.63900006 |
| 45 | MP0008995_early_reproductive_senescence | 1.63346836 |
| 46 | * MP0001800_abnormal_humoral_immune | 1.61487019 |
| 47 | MP0003866_abnormal_defecation | 1.58569058 |
| 48 | * MP0005000_abnormal_immune_tolerance | 1.57826424 |
| 49 | MP0009763_increased_sensitivity_to | 1.57291905 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.54241384 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.53240022 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.51937884 |
| 53 | * MP0002452_abnormal_antigen_presenting | 1.46064611 |
| 54 | MP0003195_calcinosis | 1.45649139 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.44908888 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.42125902 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 1.41639924 |
| 58 | MP0008469_abnormal_protein_level | 1.41366836 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.40694203 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.39364230 |
| 61 | MP0004145_abnormal_muscle_electrophysio | 1.35245209 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.34332280 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.33655780 |
| 64 | MP0003646_muscle_fatigue | 1.33443295 |
| 65 | MP0009785_altered_susceptibility_to | 1.31703520 |
| 66 | MP0001851_eye_inflammation | 1.30298095 |
| 67 | MP0001666_abnormal_nutrient_absorption | 1.28926216 |
| 68 | MP0002163_abnormal_gland_morphology | 1.28494522 |
| 69 | MP0005310_abnormal_salivary_gland | 1.23912528 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.23607919 |
| 71 | MP0005410_abnormal_fertilization | 1.22170305 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.21939916 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20827007 |
| 74 | MP0004742_abnormal_vestibular_system | 1.18679128 |
| 75 | MP0003690_abnormal_glial_cell | 1.18220637 |
| 76 | * MP0002723_abnormal_immune_serum | 1.17063268 |
| 77 | MP0000249_abnormal_blood_vessel | 1.16358723 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.16172464 |
| 79 | * MP0002420_abnormal_adaptive_immunity | 1.15966306 |
| 80 | * MP0001819_abnormal_immune_cell | 1.15274365 |
| 81 | MP0000598_abnormal_liver_morphology | 1.11518054 |
| 82 | MP0002405_respiratory_system_inflammati | 1.11110889 |
| 83 | MP0000767_abnormal_smooth_muscle | 1.10988948 |
| 84 | MP0000689_abnormal_spleen_morphology | 1.09590511 |
| 85 | MP0002254_reproductive_system_inflammat | 1.07395743 |
| 86 | MP0002095_abnormal_skin_pigmentation | 1.07064017 |
| 87 | MP0005023_abnormal_wound_healing | 1.06775454 |
| 88 | MP0004381_abnormal_hair_follicle | 1.03631585 |
| 89 | MP0005166_decreased_susceptibility_to | 1.03417404 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 1.03113538 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 1.00573875 |
| 92 | MP0001915_intracranial_hemorrhage | 1.00266763 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.99118963 |
| 94 | MP0002168_other_aberrant_phenotype | 0.95946434 |
| 95 | MP0001919_abnormal_reproductive_system | 0.95500964 |
| 96 | MP0002132_abnormal_respiratory_system | 0.95373368 |
| 97 | MP0006082_CNS_inflammation | 0.94924886 |
| 98 | * MP0000716_abnormal_immune_system | 0.92575992 |
| 99 | MP0005395_other_phenotype | 0.92309154 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.91823261 |
| 101 | MP0009764_decreased_sensitivity_to | 0.91411339 |
| 102 | MP0000858_altered_metastatic_potential | 0.90662999 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.89743348 |
| 104 | MP0000343_altered_response_to | 0.88216624 |
| 105 | MP0001853_heart_inflammation | 0.88147164 |
| 106 | MP0001661_extended_life_span | 0.88081755 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.87941597 |
| 108 | MP0002971_abnormal_brown_adipose | 0.86476466 |
| 109 | MP0003011_delayed_dark_adaptation | 0.85769040 |
| 110 | MP0001764_abnormal_homeostasis | 0.84856611 |
| 111 | MP0002019_abnormal_tumor_incidence | 0.84207846 |
| 112 | MP0005390_skeleton_phenotype | 0.84160090 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.84031666 |
| 114 | MP0005174_abnormal_tail_pigmentation | 0.82812674 |
| 115 | MP0003329_amyloid_beta_deposits | 0.82411461 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.81802483 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.81424516 |
| 118 | MP0002933_joint_inflammation | 0.81417394 |
| 119 | MP0003786_premature_aging | 0.80664056 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.80220785 |
| 121 | MP0005408_hypopigmentation | 0.78711630 |
| 122 | MP0008873_increased_physiological_sensi | 0.77178393 |
| 123 | MP0002722_abnormal_immune_system | 0.76106073 |
| 124 | MP0000465_gastrointestinal_hemorrhage | 0.75500111 |
| 125 | MP0004130_abnormal_muscle_cell | 0.74228540 |
| 126 | MP0002006_tumorigenesis | 0.73219290 |
| 127 | MP0001849_ear_inflammation | 0.72997971 |
| 128 | MP0008872_abnormal_physiological_respon | 0.72993072 |
| 129 | * MP0002429_abnormal_blood_cell | 0.72455989 |
| 130 | MP0002398_abnormal_bone_marrow | 0.72047101 |
| 131 | MP0005645_abnormal_hypothalamus_physiol | 0.71765426 |
| 132 | MP0005535_abnormal_body_temperature | 0.71704467 |
| 133 | MP0002736_abnormal_nociception_after | 0.71521148 |
| 134 | MP0003868_abnormal_feces_composition | 0.70911130 |
| 135 | MP0002998_abnormal_bone_remodeling | 0.70252044 |
| 136 | MP0000681_abnormal_thyroid_gland | 0.68253156 |
| 137 | MP0001243_abnormal_dermal_layer | 0.67966096 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.67892569 |
| 139 | MP0003718_maternal_effect | 0.66328826 |
| 140 | MP0001968_abnormal_touch/_nociception | 0.65917723 |
| 141 | MP0008877_abnormal_DNA_methylation | 0.65618401 |
| 142 | MP0005379_endocrine/exocrine_gland_phen | 0.64303650 |
| 143 | * MP0009333_abnormal_splenocyte_physiolog | 0.63907683 |
| 144 | MP0005248_abnormal_Harderian_gland | 0.63657845 |
| 145 | MP0008789_abnormal_olfactory_epithelium | 0.62594694 |
| 146 | MP0005647_abnormal_sex_gland | 0.62069531 |
| 147 | MP0005666_abnormal_adipose_tissue | 0.61819356 |
| 148 | MP0000639_abnormal_adrenal_gland | 0.60722190 |
| 149 | MP0005389_reproductive_system_phenotype | 0.60553547 |
| 150 | MP0001765_abnormal_ion_homeostasis | 0.57997595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 8.12801327 |
| 2 | Glomerulonephritis (HP:0000099) | 7.58166925 |
| 3 | Abnormality of complement system (HP:0005339) | 7.54991513 |
| 4 | T lymphocytopenia (HP:0005403) | 7.18615879 |
| 5 | Abnormality of T cell number (HP:0011839) | 7.02119108 |
| 6 | Deep venous thrombosis (HP:0002625) | 6.50526860 |
| 7 | Chronic diarrhea (HP:0002028) | 5.76975787 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.31542230 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.24638106 |
| 10 | Aplastic anemia (HP:0001915) | 4.69234527 |
| 11 | Nephritis (HP:0000123) | 4.55702548 |
| 12 | Abnormality of T cells (HP:0002843) | 4.53216723 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.29395288 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 4.24057720 |
| 15 | Joint hemorrhage (HP:0005261) | 4.07785059 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 4.03552418 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.97721206 |
| 18 | Xanthomatosis (HP:0000991) | 3.93255184 |
| 19 | Increased IgM level (HP:0003496) | 3.92121468 |
| 20 | IgG deficiency (HP:0004315) | 3.79312588 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.63295718 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 3.57103076 |
| 23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.56106271 |
| 24 | Joint swelling (HP:0001386) | 3.42187370 |
| 25 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.41011395 |
| 26 | Menorrhagia (HP:0000132) | 3.39304395 |
| 27 | Intrahepatic cholestasis (HP:0001406) | 3.38304435 |
| 28 | Recurrent viral infections (HP:0004429) | 3.36674401 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.35299554 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.35299554 |
| 31 | Shallow orbits (HP:0000586) | 3.34604004 |
| 32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.33169527 |
| 33 | Pustule (HP:0200039) | 3.31279582 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.27754212 |
| 35 | Eczematoid dermatitis (HP:0000976) | 3.27708798 |
| 36 | Peritonitis (HP:0002586) | 3.26639623 |
| 37 | Abnormality of eosinophils (HP:0001879) | 3.26287651 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 3.22959047 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.22631009 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.22631009 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.22631009 |
| 42 | Spondylolisthesis (HP:0003302) | 3.21499943 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 3.20539696 |
| 44 | Nasal polyposis (HP:0100582) | 3.17956031 |
| 45 | Granulocytopenia (HP:0001913) | 3.17551476 |
| 46 | Asymmetric septal hypertrophy (HP:0001670) | 3.15541566 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11783712 |
| 48 | Arthropathy (HP:0003040) | 3.10869721 |
| 49 | Loss of speech (HP:0002371) | 3.04338032 |
| 50 | Combined immunodeficiency (HP:0005387) | 3.01476390 |
| 51 | Carpal bone hypoplasia (HP:0001498) | 2.97238398 |
| 52 | Recurrent fungal infections (HP:0002841) | 2.94798817 |
| 53 | Abnormality of the nasal mucosa (HP:0000433) | 2.88100144 |
| 54 | Hypobetalipoproteinemia (HP:0003563) | 2.82912887 |
| 55 | Esophageal varix (HP:0002040) | 2.79891165 |
| 56 | Cervical subluxation (HP:0003308) | 2.78967421 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.77256844 |
| 58 | IgM deficiency (HP:0002850) | 2.77225239 |
| 59 | Thyroiditis (HP:0100646) | 2.76814132 |
| 60 | Recurrent bronchitis (HP:0002837) | 2.76437176 |
| 61 | Myositis (HP:0100614) | 2.75721399 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.74472080 |
| 63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.74472080 |
| 64 | Hypochromic microcytic anemia (HP:0004840) | 2.69708334 |
| 65 | Myocardial infarction (HP:0001658) | 2.69540329 |
| 66 | Hypochromic anemia (HP:0001931) | 2.69337972 |
| 67 | Hyperlipoproteinemia (HP:0010980) | 2.67865229 |
| 68 | Meningitis (HP:0001287) | 2.67643863 |
| 69 | Wrist flexion contracture (HP:0001239) | 2.64526694 |
| 70 | Leukocytosis (HP:0001974) | 2.63534448 |
| 71 | IgA deficiency (HP:0002720) | 2.63165281 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.58681416 |
| 73 | Abnormality of B cell number (HP:0010975) | 2.58620045 |
| 74 | Anorexia (HP:0002039) | 2.57236244 |
| 75 | Nausea (HP:0002018) | 2.55381441 |
| 76 | B lymphocytopenia (HP:0010976) | 2.53175325 |
| 77 | Hypoalphalipoproteinemia (HP:0003233) | 2.51299534 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.49263330 |
| 79 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49222381 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.48285264 |
| 81 | J-shaped sella turcica (HP:0002680) | 2.46463586 |
| 82 | Hypolipoproteinemia (HP:0010981) | 2.45848891 |
| 83 | Constricted visual fields (HP:0001133) | 2.45173325 |
| 84 | Amyloidosis (HP:0011034) | 2.44766323 |
| 85 | Hypoproteinemia (HP:0003075) | 2.43584742 |
| 86 | Oligomenorrhea (HP:0000876) | 2.41386223 |
| 87 | Mediastinal lymphadenopathy (HP:0100721) | 2.39980724 |
| 88 | Microcytic anemia (HP:0001935) | 2.38290899 |
| 89 | Mitral stenosis (HP:0001718) | 2.38169657 |
| 90 | Short nail (HP:0001799) | 2.36558896 |
| 91 | Eosinophilia (HP:0001880) | 2.36326065 |
| 92 | Lymphopenia (HP:0001888) | 2.35941579 |
| 93 | Abnormality of T cell physiology (HP:0011840) | 2.34953404 |
| 94 | Abnormality of the lumbar spine (HP:0100712) | 2.34939617 |
| 95 | Cholelithiasis (HP:0001081) | 2.33065694 |
| 96 | Prolonged bleeding time (HP:0003010) | 2.32788094 |
| 97 | Joint stiffness (HP:0001387) | 2.32277078 |
| 98 | Periodontitis (HP:0000704) | 2.31365663 |
| 99 | Thoracic kyphosis (HP:0002942) | 2.28724369 |
| 100 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.27106358 |
| 101 | Epidermoid cyst (HP:0200040) | 2.27009449 |
| 102 | Gingival bleeding (HP:0000225) | 2.26272003 |
| 103 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.25764122 |
| 104 | Hyperammonemia (HP:0001987) | 2.25688054 |
| 105 | Vasculitis (HP:0002633) | 2.25282942 |
| 106 | Agammaglobulinemia (HP:0004432) | 2.23689613 |
| 107 | Hyponatremia (HP:0002902) | 2.22123562 |
| 108 | Polygenic inheritance (HP:0010982) | 2.21512330 |
| 109 | Encephalitis (HP:0002383) | 2.21511799 |
| 110 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.20336471 |
| 111 | Hypercholesterolemia (HP:0003124) | 2.20310872 |
| 112 | Epistaxis (HP:0000421) | 2.19494622 |
| 113 | Spontaneous hematomas (HP:0007420) | 2.19282577 |
| 114 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.16395461 |
| 115 | Abnormality of macrophages (HP:0004311) | 2.15499393 |
| 116 | Recurrent skin infections (HP:0001581) | 2.14137521 |
| 117 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11184145 |
| 118 | Severe visual impairment (HP:0001141) | 2.09670512 |
| 119 | Gingivitis (HP:0000230) | 2.09010372 |
| 120 | Pulmonary infiltrates (HP:0002113) | 2.08909412 |
| 121 | Congenital sensorineural hearing impairment (HP:0008527) | 2.08524556 |
| 122 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08141446 |
| 123 | Abnormality of alanine metabolism (HP:0010916) | 2.08141446 |
| 124 | Hyperalaninemia (HP:0003348) | 2.08141446 |
| 125 | Cerebral aneurysm (HP:0004944) | 2.07716740 |
| 126 | Abnormal gallbladder physiology (HP:0012438) | 2.07526635 |
| 127 | Cholecystitis (HP:0001082) | 2.07526635 |
| 128 | Bronchomalacia (HP:0002780) | 2.06907344 |
| 129 | Attenuation of retinal blood vessels (HP:0007843) | 2.05411756 |
| 130 | Deformed sella turcica (HP:0002681) | 2.04806089 |
| 131 | Abnormal gallbladder morphology (HP:0012437) | 2.04270740 |
| 132 | Stomatitis (HP:0010280) | 2.03379715 |
| 133 | Lymphoma (HP:0002665) | 2.01924214 |
| 134 | Chronic obstructive pulmonary disease (HP:0006510) | 2.01870756 |
| 135 | Obstructive lung disease (HP:0006536) | 2.01870756 |
| 136 | Increased serum ferritin (HP:0003281) | 2.01738851 |
| 137 | Arterial thrombosis (HP:0004420) | 2.01059805 |
| 138 | Systemic lupus erythematosus (HP:0002725) | 10.6483908 |
| 139 | Fatigue (HP:0012378) | 1.99968643 |
| 140 | Toxemia of pregnancy (HP:0100603) | 1.99619592 |
| 141 | Hemoptysis (HP:0002105) | 1.98784253 |
| 142 | Poikilocytosis (HP:0004447) | 1.96745882 |
| 143 | Enlarged penis (HP:0000040) | 1.95363659 |
| 144 | Inflammation of the large intestine (HP:0002037) | 1.92759942 |
| 145 | Pulmonary embolism (HP:0002204) | 1.91552370 |
| 146 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.90243370 |
| 147 | Neutropenia (HP:0001875) | 1.89417404 |
| 148 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.88591141 |
| 149 | Turricephaly (HP:0000262) | 1.88146819 |
| 150 | Increased intramyocellular lipid droplets (HP:0012240) | 1.88100041 |
| 151 | Hand muscle atrophy (HP:0009130) | 1.87297041 |
| 152 | Acute hepatic failure (HP:0006554) | 1.86877025 |
| 153 | Pancytopenia (HP:0001876) | 1.86860739 |
| 154 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.86488728 |
| 155 | Ketosis (HP:0001946) | 1.85965498 |
| 156 | Abnormality of homocysteine metabolism (HP:0010919) | 1.85724441 |
| 157 | Homocystinuria (HP:0002156) | 1.85724441 |
| 158 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84540100 |
| 159 | Colitis (HP:0002583) | 1.84045474 |
| 160 | Neurofibrillary tangles (HP:0002185) | 1.83575267 |
| 161 | Multifactorial inheritance (HP:0001426) | 1.82595397 |
| 162 | Arterial tortuosity (HP:0005116) | 1.82443776 |
| 163 | Thrombophlebitis (HP:0004418) | 1.81060290 |
| 164 | Purpura (HP:0000979) | 1.80632549 |
| 165 | Urticaria (HP:0001025) | 1.80056780 |
| 166 | Retrobulbar optic neuritis (HP:0100654) | 1.80032799 |
| 167 | Optic neuritis (HP:0100653) | 1.80032799 |
| 168 | Abnormality of methionine metabolism (HP:0010901) | 1.77962459 |
| 169 | Abnormality of nucleobase metabolism (HP:0010932) | 1.77080977 |
| 170 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.76617705 |
| 171 | Coarse hair (HP:0002208) | 1.74884816 |
| 172 | Fat malabsorption (HP:0002630) | 1.73647670 |
| 173 | Hypoglycemic coma (HP:0001325) | 1.73583852 |
| 174 | Broad metatarsal (HP:0001783) | 1.72036576 |
| 175 | Beaking of vertebral bodies (HP:0004568) | 1.72003269 |
| 176 | Hemorrhage of the eye (HP:0011885) | 1.71949520 |
| 177 | Abnormality of purine metabolism (HP:0004352) | 1.71325895 |
| 178 | Ovoid vertebral bodies (HP:0003300) | 1.70189032 |
| 179 | Pathologic fracture (HP:0002756) | 1.67642495 |
| 180 | Renal tubular acidosis (HP:0001947) | 1.67641164 |
| 181 | Flat acetabular roof (HP:0003180) | 1.66309928 |
| 182 | Abnormality of iron homeostasis (HP:0011031) | 1.64744481 |
| 183 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.64174168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 6.49197868 |
| 2 | TXK | 4.81837631 |
| 3 | TESK2 | 4.54502314 |
| 4 | PIK3CA | 3.85623582 |
| 5 | ERN1 | 3.71551216 |
| 6 | TAOK3 | 3.59684105 |
| 7 | ITK | 3.48381144 |
| 8 | BLK | 3.30990193 |
| 9 | CAMK1D | 3.21587175 |
| 10 | TYK2 | 2.86824878 |
| 11 | TRIB3 | 2.66962616 |
| 12 | MAP4K1 | 2.54921823 |
| 13 | VRK2 | 2.53495295 |
| 14 | DAPK2 | 2.49085757 |
| 15 | MET | 2.34944523 |
| 16 | CAMK1G | 2.28536847 |
| 17 | RIPK1 | 2.25054448 |
| 18 | TNK2 | 2.21558810 |
| 19 | EIF2AK3 | 2.17188667 |
| 20 | PKN2 | 2.08921813 |
| 21 | EPHB1 | 2.07544122 |
| 22 | MAP3K13 | 1.93685815 |
| 23 | TBK1 | 1.90955699 |
| 24 | FGFR4 | 1.85428225 |
| 25 | PRKCQ | 1.85050385 |
| 26 | BMX | 1.82969164 |
| 27 | TEC | 1.57851036 |
| 28 | NUAK1 | 1.53236865 |
| 29 | MAP3K6 | 1.49064217 |
| 30 | TLK1 | 1.49000359 |
| 31 | JAK1 | 1.47606526 |
| 32 | STK10 | 1.47225335 |
| 33 | TESK1 | 1.46657120 |
| 34 | TGFBR2 | 1.45514458 |
| 35 | ZAK | 1.44512789 |
| 36 | GRK6 | 1.43786648 |
| 37 | VRK1 | 1.42537461 |
| 38 | IKBKE | 1.30278685 |
| 39 | IRAK4 | 1.28601767 |
| 40 | CSK | 1.27781249 |
| 41 | KIT | 1.26646670 |
| 42 | PTK6 | 1.26291635 |
| 43 | MAP3K14 | 1.24776611 |
| 44 | FES | 1.24348531 |
| 45 | FGR | 1.19427786 |
| 46 | ZAP70 | 1.17531421 |
| 47 | SIK1 | 1.17170375 |
| 48 | BCKDK | 1.16081666 |
| 49 | MAP3K12 | 1.09159749 |
| 50 | HCK | 1.05551878 |
| 51 | EPHA3 | 1.05133881 |
| 52 | ACVR1B | 0.99617796 |
| 53 | JAK3 | 0.99446756 |
| 54 | MAP3K11 | 0.99205441 |
| 55 | ERBB4 | 0.95624065 |
| 56 | CSF1R | 0.94283355 |
| 57 | MAP2K3 | 0.92478977 |
| 58 | JAK2 | 0.91637543 |
| 59 | PRKCH | 0.90818669 |
| 60 | CLK1 | 0.86971622 |
| 61 | TTN | 0.86117564 |
| 62 | EEF2K | 0.85875555 |
| 63 | IKBKB | 0.83017429 |
| 64 | PRKAA2 | 0.78654875 |
| 65 | MAP3K10 | 0.76987730 |
| 66 | EIF2AK1 | 0.74304813 |
| 67 | SYK | 0.73944819 |
| 68 | LRRK2 | 0.73846324 |
| 69 | CAMKK1 | 0.73381358 |
| 70 | EPHB2 | 0.72223143 |
| 71 | RIPK4 | 0.71388428 |
| 72 | STK38 | 0.70436423 |
| 73 | NTRK2 | 0.69988350 |
| 74 | MAP2K4 | 0.69853985 |
| 75 | IGF1R | 0.68997679 |
| 76 | LCK | 0.68453450 |
| 77 | BTK | 0.67663162 |
| 78 | MST4 | 0.65096696 |
| 79 | PIM1 | 0.64672167 |
| 80 | BUB1 | 0.64607994 |
| 81 | MAP3K7 | 0.63883515 |
| 82 | PIK3CG | 0.63741717 |
| 83 | MAPK12 | 0.63706341 |
| 84 | SIK2 | 0.62707022 |
| 85 | MARK3 | 0.61696750 |
| 86 | LATS1 | 0.60424281 |
| 87 | MAPK11 | 0.58453141 |
| 88 | EGFR | 0.57256314 |
| 89 | CHUK | 0.56843834 |
| 90 | INSRR | 0.56574645 |
| 91 | DAPK1 | 0.56050869 |
| 92 | NEK9 | 0.54516184 |
| 93 | GRK1 | 0.54135775 |
| 94 | FLT3 | 0.54113175 |
| 95 | ARAF | 0.54076851 |
| 96 | MYLK | 0.53950007 |
| 97 | GRK7 | 0.53872492 |
| 98 | ABL2 | 0.53639020 |
| 99 | MAP3K1 | 0.53082383 |
| 100 | FGFR3 | 0.51771651 |
| 101 | KSR2 | 0.51540163 |
| 102 | DAPK3 | 0.50443642 |
| 103 | PKN1 | 0.49524441 |
| 104 | PDPK1 | 0.49131486 |
| 105 | INSR | 0.48895583 |
| 106 | ADRBK2 | 0.48290680 |
| 107 | ADRBK1 | 0.46918795 |
| 108 | RPS6KA4 | 0.46861536 |
| 109 | AURKA | 0.46512714 |
| 110 | STK3 | 0.45351433 |
| 111 | RET | 0.45013186 |
| 112 | CAMKK2 | 0.42858161 |
| 113 | MATK | 0.42776222 |
| 114 | CDK4 | 0.42537754 |
| 115 | MUSK | 0.42420574 |
| 116 | MOS | 0.42094896 |
| 117 | LYN | 0.41833582 |
| 118 | TIE1 | 0.41634417 |
| 119 | MAP3K9 | 0.41501958 |
| 120 | RPS6KA2 | 0.40039920 |
| 121 | BMPR2 | 0.38837875 |
| 122 | MAPKAPK2 | 0.38699697 |
| 123 | ROCK1 | 0.38684922 |
| 124 | PRKCA | 0.37958811 |
| 125 | PRKCD | 0.37794783 |
| 126 | KDR | 0.35455186 |
| 127 | TAOK2 | 0.35105345 |
| 128 | BCR | 0.34903333 |
| 129 | PLK4 | 0.32739143 |
| 130 | RPS6KA5 | 0.32292312 |
| 131 | CAMK2A | 0.32173675 |
| 132 | PDK1 | 0.31972513 |
| 133 | PAK1 | 0.31963409 |
| 134 | TAOK1 | 0.30996498 |
| 135 | FYN | 0.30382292 |
| 136 | STK24 | 0.28308017 |
| 137 | SGK3 | 0.27720225 |
| 138 | FGFR1 | 0.27669564 |
| 139 | CSNK1A1 | 0.26886532 |
| 140 | PTK2 | 0.26538397 |
| 141 | GSK3A | 0.25364638 |
| 142 | MAP3K3 | 0.24918751 |
| 143 | CDK9 | 0.24859067 |
| 144 | SCYL2 | 0.24495058 |
| 145 | MELK | 0.24313892 |
| 146 | MAPK4 | 0.24283588 |
| 147 | MAPK3 | 0.24086110 |
| 148 | SRC | 0.23949668 |
| 149 | PRKACA | 0.23426569 |
| 150 | PRKCB | 0.22872335 |
| 151 | MAP2K1 | 0.21148895 |
| 152 | LMTK2 | 0.20965023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 6.83990833 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.19726837 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.89933783 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.63077833 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 4.10200500 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.98899792 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 3.54385104 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.46760731 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.25463201 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.23766467 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18454455 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.07475640 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.97335679 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.62330314 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.49910508 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.42586711 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.41038280 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 2.39581656 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.28717325 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.21434857 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.18122124 |
| 22 | Asthma_Homo sapiens_hsa05310 | 2.17800144 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.94401965 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90018162 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.83438499 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71792052 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.65956688 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.60675914 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59093480 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56890104 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.48135228 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45873941 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42302293 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35176543 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34250225 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.33302428 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31624054 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.30717652 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.28809424 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.26402465 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.25861102 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23977760 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.22026205 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18963912 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16122727 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15748584 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12472140 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.11029248 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 1.09458682 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06985969 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06904513 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 1.06026680 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00939700 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98499927 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98210859 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.97646691 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96625125 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92436034 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92372306 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91620317 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91085105 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.89901116 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.89658103 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88920443 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84804551 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83584894 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82787429 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77260029 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76485185 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73456232 |
| 71 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68901915 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.68822583 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66329239 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65333645 |
| 75 | Protein export_Homo sapiens_hsa03060 | 0.65016401 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.64242498 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63233748 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62608752 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.60578331 |
| 80 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59658681 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59381806 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59003927 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58538046 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58243580 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58177396 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57912616 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55758561 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55428281 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.55411391 |
| 90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53037811 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.52416649 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51428086 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.50849973 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.50680558 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50359317 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49858896 |
| 97 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49829454 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48434732 |
| 99 | RNA polymerase_Homo sapiens_hsa03020 | 0.47270272 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47249504 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46518988 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45320921 |
| 103 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44930646 |
| 104 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44747476 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44747141 |
| 106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43884066 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43634656 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42963290 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42531773 |
| 110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41651930 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41250298 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.40754901 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40408066 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.39031163 |
| 115 | Ribosome_Homo sapiens_hsa03010 | 0.38894941 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36892707 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34390238 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33633017 |
| 119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33278176 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32841711 |
| 121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31368092 |
| 122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30888802 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30834449 |
| 124 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30012977 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.28812177 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27290101 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.26734855 |
| 128 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26160530 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25944073 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.25655206 |
| 131 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.25154375 |
| 132 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.25002294 |
| 133 | Hepatitis C_Homo sapiens_hsa05160 | 0.24619097 |
| 134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24211485 |
| 135 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.24198101 |
| 136 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23485012 |
| 137 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.23391844 |
| 138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.22092797 |
| 139 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.21270703 |
| 140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20817003 |
| 141 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19882072 |
| 142 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.19290896 |
| 143 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18983880 |
| 144 | Measles_Homo sapiens_hsa05162 | 0.17522790 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17447927 |
| 146 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.17371572 |
| 147 | Alcoholism_Homo sapiens_hsa05034 | 0.16646162 |
| 148 | Basal transcription factors_Homo sapiens_hsa03022 | 0.13974125 |
| 149 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.12541890 |
| 150 | Morphine addiction_Homo sapiens_hsa05032 | 0.11342460 |
| 151 | Homologous recombination_Homo sapiens_hsa03440 | 0.10261067 |

